Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
Chris Lai
METiS Pharmaceuticals is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
July 2022 – November 2026 · 8 captures · latest observed messagingMETiS TechBio
4 July 2022 · METiS Therapeutics | AI drug discoveryarchived page
14 February 2023 · METiS Therapeutics | AI drug discoveryarchived page
3 October 2023 · METiS Therapeutics | AI drug discoveryarchived page
5 March 2024 · METiS Therapeutics | AI drug discoveryarchived page
21 January 2025 · METiS Therapeutics | AI drug discoveryarchived page
19 July 2025 · METiS Therapeutics | AI drug discoveryarchived page
14 January 2026 · METiS Therapeutics | AI drug discoveryarchived page
6 November 2026 · METiS TechBiocurrent websiteHistorical capture not publicly available
Seen December 2021 · 1 captureChris Lai
METiS Pharmaceuticals is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.